Yüklüyor......
A randomized, double‐blind, placebo‐ and positive‐controlled crossover study of the effects of durlobactam on cardiac repolarization in healthy subjects
Durlobactam (formerly ETX2514) is a diazabicyclooctane β‐lactamase inhibitor that inhibits class A, C, and D β‐lactamases. Sulbactam combined with durlobactam has in vitro and in vivo activity against Acinetobacter baumannii including carbapenem‐ and colistin‐resistant isolates and is being develope...
Kaydedildi:
| Yayımlandı: | Clin Transl Sci |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301544/ https://ncbi.nlm.nih.gov/pubmed/33934519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12991 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|